Trials / Sponsors / Monopar Therapeutics
Monopar Therapeutics
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors Solid Tumor, Adult, Bladder Cancer, Urothelial Carcinoma | Phase 1 | 2024-10-08 |
| Recruiting | Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors Solid Tumor, Adult, Bladder Cancer, Urothelial Carcinoma | Phase 1 | 2024-05-30 |
| Terminated | Camsirubicin + Pegfilgrastim to Determine MTD in ASTS Advanced Soft-tissue Sarcoma | Phase 1 | 2021-09-22 |
| Terminated | Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Canc Chemoradiotherapy-Induced Severe Oral Mucositis | Phase 2 / Phase 3 | 2021-02-11 |
| Available | MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer Cancer, Solid Tumor, Solid Tumor, Adult | — | — |
| Available | MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer Cancer, Solid Tumor, Solid Tumor Cancer | — | — |